Top Markets
#1 SAFEcoin SAFEcoin +32.96%
#2 Zora Zora +29.49%
#3 AI XOVIA AI XOVIA +22.03%
#4 Helium Helium +21.85%
#5 Full Moon Full Moon +19.85%
#6 Merlin's Seal BTC Merlin's Seal BTC +16.10%
#7 0G 0G +15.13%
#8 Axelar Axelar +14.88%
#9 Bless Bless +13.79%
#10 VVS Finance VVS Finance +13.70%
Coin of the day
SAFEcoin SAFEcoin
설정
언어
한국어
통화
USD
테마
Graphite Bio, Inc. Graphite Bio, Inc.

Graphite Bio, Inc.

GRPH
주식 순위 #12751
Graphite Bio, Inc. is a clinical-stage gene editing company dedicated to... Graphite Bio, Inc. is a clinical-stage gene editing company dedicated to developing innovative therapeutic solutions for severe and life-threatening illnesses across the United States. Its primary investigational therapy, GPH101, is an autologous, gene-edited hematopoietic stem cell product specifically engineered to directly correct the underlying mutation causing sickle cell disease, thereby restoring normal adult hemoglobin production. The company's pipeline also features GPH201, intended for the treatment of X-linked severe combined immunodeficiency syndrome, and GPH301, an experimental candidate designed to address Gaucher disease, a genetic disorder characterized by a deficiency in the glucocerebrosidase enzyme. Initially established as Integral Medicines, Inc., the company rebranded to Graphite Bio, Inc. in August 2020. Founded in 2017, Graphite Bio's operations are based out of its headquarters in South San Francisco, California.
주가
$22.26
마지막 동기화: 2024-03-22
시가총액
$553.40M
변동 (1일)
0.00%
변동 (1년)
0.00%
국가
US
거래 Graphite Bio, Inc. (GRPH)

카테고리

Healthcare
Graphite Bio, Inc. (GRPH)의 배당 수익률 기록
Graphite Bio, Inc. (주식 심볼: GRPH)의 배당 수익률 (TTM)은 2026 기준으로 0입니다.
지난 5년 평균 배당 수익률: 0.00%
Graphite Bio, Inc. (GRPH)의 배당 수익률 기록: 2026 ~ 2026
연도별 말 기준 배당 수익률 (TTM)
연도 배당 수익률 변화
제공된 날짜에 대한 데이터가 충분하지 않습니다.
유사 기업 또는 경쟁사의 배당 수익률 (TTM)
회사 배당 수익률 국가
Vertex Pharmaceuticals Incorporated Vertex Pharmaceuticals Incorporated
Vertex Pharmaceuticals Incorporated
VRTX.US
0.00%
US
Argenx SE Argenx SE
Argenx SE
ARGX.US
0.00%
NL
CSL Limited CSL Limited
CSL Limited
CSL.AX
3.12%
AU
Moderna, Inc. Moderna, Inc.
Moderna, Inc.
MRNA.US
0.00%
US
Lonza Group AG Lonza Group AG
Lonza Group AG
LONN.SW
0.00%
CH